Literature DB >> 2250980

Serum immunoglobulin status of psychiatric in-patients.

A S Sane1, M S Chawla, S A Chokshi, V Mathur, D P Barad, V C Shah, M J Patel.   

Abstract

In view of the fact that substantial evidence today links psyche, brain, stress and immune system, the serum immunoglobulin (viz. IgG, IgA, IgM) levels in 40 patients with psychiatric disorders (viz. Schizophrenia, Affective disorder and generalized Anxiety disorders) have been investigated. With the exception of IgA, all psychiatric patients had significantly elevated IgG, IgM levels (p less than 0.001) when compared with healthy controls. Surprisingly these immunoglobulin levels irrespective of prevalent psychiatric disorder were almost similar to those of the hospitalized surgical patients pre-operatively (preferable controls), suggestive of no direct linear causal relationship between the psychiatric disorder and serum immunoglobulin levels. Factors affecting immunoglobulins have been discussed. Considering a probable viral association in Schizophrenia it is felt that simultaneous monitoring of viruses (affecting the nervous system) in the form of antigen/antibodies may be more informative.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2250980

Source DB:  PubMed          Journal:  Panminerva Med        ISSN: 0031-0808            Impact factor:   5.197


  2 in total

1.  Anxiety and depression in patients with rheumatoid arthritis.

Authors:  Ahmet Isik; Suleyman Serdar Koca; Abdullah Ozturk; Osman Mermi
Journal:  Clin Rheumatol       Date:  2006-08-29       Impact factor: 3.650

2.  Immunoglobulin sub-class distribution in bipolar disorder and schizophrenia: potential relationship with latent Toxoplasma Gondii infection.

Authors:  Nora Hamdani; Djaouida Bengoufa; Ophélia Godin; Raphaël Doukhan; Emmanuel Le Guen; Claire Daban-Huard; Meriem Bennabi; Marine Delavest; Jean-Pierre Lépine; Wahid Boukouaci; Hakim Laouamri; Josselin Houenou; Stéphane Jamain; Jean-Romain Richard; Philippe Lecorvosier; Robert Yolken; Krishnamoorthy Rajagopal; Marion Leboyer; Ryad Tamouza
Journal:  BMC Psychiatry       Date:  2018-07-27       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.